Caricamento...
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
BACKGROUND: Several studies have identified the decreased expression of the tumor suppressor miR-101 in various cancers. In this study, we tested miR-101 as a potential therapeutic target and novel plasma biomarker for gastric cancer (GC). RESULTS: The miR-101 expression level was significantly lowe...
Salvato in:
| Pubblicato in: | Oncotarget |
|---|---|
| Autori principali: | , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Impact Journals LLC
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739754/ https://ncbi.nlm.nih.gov/pubmed/29290969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20860 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|